Alx Oncology Holdings Stock Buy Hold or Sell Recommendation

ALXO Stock  USD 1.41  0.12  9.30%   
Given the investment horizon of 90 days and your slightly conservative level of risk, our recommendation regarding Alx Oncology Holdings is 'Strong Sell'. The recommendation algorithm takes into account all of Alx Oncology's available fundamental, technical, and predictive indicators you will find on this site.
  
Check out Alx Oncology Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
In addition, we conduct extensive research on individual companies such as Alx and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Alx Oncology Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

Execute Alx Oncology Buy or Sell Advice

The Alx recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Alx Oncology Holdings. Macroaxis does not own or have any residual interests in Alx Oncology Holdings or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Alx Oncology's advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Alx OncologyBuy Alx Oncology
Strong Sell

Market Performance

Very WeakDetails

Volatility

DangerousDetails

Hype Condition

StaleDetails

Current Valuation

Fairly ValuedDetails

Odds Of Distress

Very HighDetails

Economic Sensitivity

Moves slightly opposite to the marketDetails

Investor Sentiment

AlarmedDetails

Analyst Consensus

Strong BuyDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

UnavailableDetails
For the selected time horizon Alx Oncology Holdings has a Mean Deviation of 3.44, Standard Deviation of 4.5 and Variance of 20.28
We provide trade advice to complement the prevailing expert consensus on Alx Oncology Holdings. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Alx Oncology is not overpriced, please confirm all Alx Oncology Holdings fundamentals, including its cash flow from operations, and the relationship between the cash per share and beta . Please also double-check Alx Oncology Holdings price to book to validate your buy or sell decision is consistent with all fundamental data available and that the company can sustain itself in the current economic cycle.

Alx Oncology Trading Alerts and Improvement Suggestions

Alx Oncology generated a negative expected return over the last 90 days
Alx Oncology may become a speculative penny stock
Alx Oncology has high historical volatility and very poor performance
Alx Oncology has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (160.81 M) with profit before overhead, payroll, taxes, and interest of 107 K.
Alx Oncology Holdings currently holds about 313.37 M in cash with (130.36 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 7.69, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Over 92.0% of the company shares are held by institutions such as insurance companies
Latest headline from zacks.com: ALX Oncology Holdings Loses -27.11 percent in 4 Weeks, Heres Why a Trend Reversal May be Around the Corner

Alx Oncology Returns Distribution Density

The distribution of Alx Oncology's historical returns is an attempt to chart the uncertainty of Alx Oncology's future price movements. The chart of the probability distribution of Alx Oncology daily returns describes the distribution of returns around its average expected value. We use Alx Oncology Holdings price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Alx Oncology returns is essential to provide solid investment advice for Alx Oncology.
Mean Return
-0.9
Value At Risk
-7.76
Potential Upside
6.94
Standard Deviation
4.50
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Alx Oncology historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Alx Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument, such as Alx Oncology, soars without any apparent reason. This usually happens because many institutional investors are aggressively trading Alx Oncology Holdings back and forth among themselves. Companies that invest excess capital in these types of assets may also be included in this term and can influence corporate governance by exercising voting rights in their investments.
Shares
State Street Corp2024-06-30
705.5 K
Geode Capital Management, Llc2024-06-30
700.4 K
Marshall Wace Asset Management Ltd2024-06-30
635.7 K
Privium Fund Management B.v.2024-09-30
509.1 K
Northern Trust Corp2024-09-30
319.7 K
Kennedy Capital Management Inc2024-06-30
307.5 K
Point72 Asset Management, L.p.2024-06-30
304.1 K
Two Sigma Investments Llc2024-06-30
292.2 K
Los Angeles Capital Management Llc2024-09-30
257.8 K
Venbio Partners Llc2024-06-30
9.7 M
Fmr Inc2024-09-30
5.9 M
Note, although Alx Oncology's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Alx Oncology Cash Flow Accounts

201920202021202220232024 (projected)
Investments(353K)610K(4.9M)(234.0M)44.7M46.9M
Change In Cash755K425.2M(70.6M)(314.8M)(26.4M)(25.1M)
Free Cash Flow(14.6M)(38.3M)(73.0M)(90.7M)(131.6M)(125.1M)
Depreciation429K202K51K342K836K420.0K
Other Non Cash Items11K295K5.4M228K(5.0M)(4.7M)
Capital Expenditures353K31K4.9M1.4M1.3M1.6M
Net Income(19.2M)(45.7M)(83.5M)(123.5M)(160.8M)(152.8M)
End Period Cash Flow9.0M434.2M363.7M48.9M22.5M21.3M
Change To Netincome297K6.6M19.3M23.8M27.4M28.8M

Alx Oncology Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Alx Oncology or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Alx Oncology's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Alx stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
-1.11
β
Beta against Dow Jones2.00
σ
Overall volatility
4.55
Ir
Information ratio -0.22

Alx Oncology Volatility Alert

Alx Oncology Holdings exhibits very low volatility with skewness of 0.06 and kurtosis of 0.53. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Alx Oncology's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Alx Oncology's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.

Alx Oncology Fundamentals Vs Peers

Comparing Alx Oncology's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Alx Oncology's direct or indirect competition across all of the common fundamentals between Alx Oncology and the related equities. This way, we can detect undervalued stocks with similar characteristics as Alx Oncology or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Alx Oncology's fundamental indicators could also be used in its relative valuation, which is a method of valuing Alx Oncology by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Alx Oncology to competition
FundamentalsAlx OncologyPeer Average
Return On Equity-0.99-0.31
Return On Asset-0.49-0.14
Current Valuation(70.7 M)16.62 B
Shares Outstanding52.74 M571.82 M
Shares Owned By Insiders1.91 %10.09 %
Shares Owned By Institutions92.44 %39.21 %
Number Of Shares Shorted7.84 M4.71 M
Price To Book0.50 X9.51 X
Price To Sales5,906 X11.42 X
Gross Profit107 K27.38 B
EBITDA(158.4 M)3.9 B
Net Income(160.81 M)570.98 M
Cash And Equivalents313.37 M2.7 B
Cash Per Share7.69 X5.01 X
Total Debt17.2 M5.32 B
Debt To Equity0.02 %48.70 %
Current Ratio13.23 X2.16 X
Book Value Per Share2.59 X1.93 K
Cash Flow From Operations(130.36 M)971.22 M
Short Ratio11.81 X4.00 X
Earnings Per Share(2.97) X3.12 X
Target Price9.33
Number Of Employees8918.84 K
Beta1.04-0.15
Market Capitalization68.04 M19.03 B
Total Asset242.55 M29.47 B
Retained Earnings(486.27 M)9.33 B
Working Capital152.66 M1.48 B
Net Asset242.55 M
Note: Acquisition by Sandler Alan B. of 600000 shares of Alx Oncology at 1.22 subject to Rule 16b-3 [view details]

Alx Oncology Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Alx . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Alx Oncology Buy or Sell Advice

When is the right time to buy or sell Alx Oncology Holdings? Buying financial instruments such as Alx Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Alx Oncology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Farming Thematic Idea Now

Farming
Farming Theme
Companies producing farming products and providing services for farmers. The Farming theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Farming Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Alx Oncology Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alx Oncology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alx Oncology Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alx Oncology Holdings Stock:
Check out Alx Oncology Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alx Oncology. If investors know Alx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alx Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.97)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.49)
Return On Equity
(0.99)
The market value of Alx Oncology Holdings is measured differently than its book value, which is the value of Alx that is recorded on the company's balance sheet. Investors also form their own opinion of Alx Oncology's value that differs from its market value or its book value, called intrinsic value, which is Alx Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alx Oncology's market value can be influenced by many factors that don't directly affect Alx Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alx Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alx Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alx Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.